Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 14530 | 764 | 32.9 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
| 1744 | 2 | CATHEPSIN//CATHEPSIN K//CATHEPSIN B | 6503 |
| 14530 | 1 | CATHEPSIN D//PROCATHEPSIN D//UNITE HORMONES CANC | 764 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CATHEPSIN D | authKW | 3108850 | 36% | 28% | 273 |
| 2 | PROCATHEPSIN D | authKW | 750465 | 3% | 72% | 26 |
| 3 | UNITE HORMONES CANC | address | 139875 | 1% | 50% | 7 |
| 4 | U148 | address | 129479 | 1% | 36% | 9 |
| 5 | CATHEPSIN D INHIBITORS | authKW | 119899 | 0% | 100% | 3 |
| 6 | ALP56 | authKW | 79933 | 0% | 100% | 2 |
| 7 | CATHEPSIN D ISOFORMS | authKW | 79933 | 0% | 100% | 2 |
| 8 | LYSOSOMAL PROTEINASES | authKW | 58128 | 1% | 36% | 4 |
| 9 | ACTIVATION PEPTIDE | authKW | 43434 | 1% | 22% | 5 |
| 10 | 37 KD PROTEIN BAND | authKW | 39966 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 2658 | 31% | 0% | 240 |
| 2 | Biochemistry & Molecular Biology | 785 | 29% | 0% | 224 |
| 3 | Pathology | 320 | 6% | 0% | 49 |
| 4 | Cell Biology | 229 | 11% | 0% | 82 |
| 5 | Medical Laboratory Technology | 123 | 2% | 0% | 18 |
| 6 | Endocrinology & Metabolism | 99 | 6% | 0% | 43 |
| 7 | Obstetrics & Gynecology | 88 | 4% | 0% | 31 |
| 8 | Biophysics | 37 | 4% | 0% | 28 |
| 9 | Neurosciences | 26 | 6% | 0% | 47 |
| 10 | Anatomy & Morphology | 22 | 1% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | UNITE HORMONES CANC | 139875 | 1% | 50% | 7 |
| 2 | U148 | 129479 | 1% | 36% | 9 |
| 3 | AKH VIENNA PATHOLGYNAECOPATHOL UNIT | 39966 | 0% | 100% | 1 |
| 4 | BIOCHIM CNRS UA 1191 | 39966 | 0% | 100% | 1 |
| 5 | BIOMETRY ROSWELL PK | 39966 | 0% | 100% | 1 |
| 6 | CANC PROGNOST MARKERS HELLEN STUDY GRP | 39966 | 0% | 100% | 1 |
| 7 | CHEMOTHER Y TUMOR MARKERS | 39966 | 0% | 100% | 1 |
| 8 | CLIN THORACOSURG | 39966 | 0% | 100% | 1 |
| 9 | CORE RUMENT IL BASIC MED SCI | 39966 | 0% | 100% | 1 |
| 10 | CRIC VAL AURELLE PAUL LAMARQUE | 39966 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BREAST CANCER RESEARCH AND TREATMENT | 1762 | 2% | 0% | 18 |
| 2 | ANTICANCER RESEARCH | 1488 | 4% | 0% | 27 |
| 3 | EUROPEAN JOURNAL OF CANCER | 1133 | 2% | 0% | 17 |
| 4 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1103 | 1% | 1% | 5 |
| 5 | INVASION & METASTASIS | 815 | 0% | 1% | 3 |
| 6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 800 | 2% | 0% | 14 |
| 7 | ACTA BIOLOGICA ET MEDICA GERMANICA | 702 | 0% | 1% | 3 |
| 8 | VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 595 | 0% | 1% | 2 |
| 9 | ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B | 561 | 0% | 1% | 1 |
| 10 | FOLIA HISTOCHEMICA ET CYTOBIOLOGICA | 557 | 1% | 0% | 5 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CATHEPSIN D | 3108850 | 36% | 28% | 273 | Search CATHEPSIN+D | Search CATHEPSIN+D |
| 2 | PROCATHEPSIN D | 750465 | 3% | 72% | 26 | Search PROCATHEPSIN+D | Search PROCATHEPSIN+D |
| 3 | CATHEPSIN D INHIBITORS | 119899 | 0% | 100% | 3 | Search CATHEPSIN+D+INHIBITORS | Search CATHEPSIN+D+INHIBITORS |
| 4 | ALP56 | 79933 | 0% | 100% | 2 | Search ALP56 | Search ALP56 |
| 5 | CATHEPSIN D ISOFORMS | 79933 | 0% | 100% | 2 | Search CATHEPSIN+D+ISOFORMS | Search CATHEPSIN+D+ISOFORMS |
| 6 | LYSOSOMAL PROTEINASES | 58128 | 1% | 36% | 4 | Search LYSOSOMAL+PROTEINASES | Search LYSOSOMAL+PROTEINASES |
| 7 | ACTIVATION PEPTIDE | 43434 | 1% | 22% | 5 | Search ACTIVATION+PEPTIDE | Search ACTIVATION+PEPTIDE |
| 8 | 37 KD PROTEIN BAND | 39966 | 0% | 100% | 1 | Search 37+KD+PROTEIN+BAND | Search 37+KD+PROTEIN+BAND |
| 9 | ACIDIC GELATINASES | 39966 | 0% | 100% | 1 | Search ACIDIC+GELATINASES | Search ACIDIC+GELATINASES |
| 10 | ACTIVE PROCESSED CATHEPSIN D | 39966 | 0% | 100% | 1 | Search ACTIVE+PROCESSED+CATHEPSIN+D | Search ACTIVE+PROCESSED+CATHEPSIN+D |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | NICOTRA, G , CASTINO, R , FOLLO, C , PERACCHIO, C , VALENTE, G , ISIDORO, C , (2010) THE DILEMMA: DOES TISSUE EXPRESSION OF CATHEPSIN D REFLECT TUMOR MALIGNANCY? THE QUESTION: DOES THE ASSAY TRULY MIRROR CATHEPSIN D MIS-FUNCTION IN THE TUMOR?.CANCER BIOMARKERS. VOL. 7. ISSUE 1. P. 47 -64 | 122 | 64% | 13 |
| 2 | LETO, G , TUMMINELLO, FM , CRESCIMANNO, M , FLANDINA, C , GEBBIA, N , (2004) CATHEPSIN D EXPRESSION LEVELS IN NONGYNECOLOGICAL SOLID TUMORS: CLINICAL AND THERAPEUTIC IMPLICATIONS.CLINICAL & EXPERIMENTAL METASTASIS. VOL. 21. ISSUE 2. P. 91-106 | 97 | 60% | 53 |
| 3 | WESTLEY, BR , MAY, FEB , (1996) CATHEPSIN D AND BREAST CANCER.EUROPEAN JOURNAL OF CANCER. VOL. 32A. ISSUE 1. P. 15-24 | 57 | 81% | 67 |
| 4 | BENES, P , VETVICKA, V , FUSEK, M , (2008) CATHEPSIN D-MANY FUNCTIONS OF ONE ASPARTIC PROTEASE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 68. ISSUE 1. P. 12-28 | 67 | 35% | 188 |
| 5 | LIAUDET-COOPMAN, E , BEAUJOUIN, M , DEROCQ, D , GARCIA, M , GLONDU-LASSIS, M , LAURENT-MATHA, V , PREBOIS, C , ROCHEFORT, H , VIGNON, F , (2006) CATHEPSIN D: NEWLY DISCOVERED FUNCTIONS OF A LONG-STANDING ASPARTIC PROTEASE IN CANCER AND APOPTOSIS.CANCER LETTERS. VOL. 237. ISSUE 2. P. 167-179 | 52 | 46% | 166 |
| 6 | VASHISHTA, A , FUSEK, M , VETVICKA, V , (2005) POSSIBLE ROLE OF PROCATHEPSIN D IN HUMAN CANCER.FOLIA MICROBIOLOGICA. VOL. 50. ISSUE 1. P. 71 -76 | 37 | 86% | 2 |
| 7 | VETVICKA, V , BENES, P , FUSEK, M , (2002) PROCATHEPSIN D IN BREAST CANCER: WHAT DO WE KNOW? EFFECTS OF RIBOZYMES AND OTHER INHIBITORS.CANCER GENE THERAPY. VOL. 9. ISSUE 10. P. 854 -863 | 47 | 71% | 16 |
| 8 | MINAROWSKA, A , GACKO, M , KARWOWSKA, A , MINAROWSKI, L , (2008) HUMAN CATHEPSIN D.FOLIA HISTOCHEMICA ET CYTOBIOLOGICA. VOL. 46. ISSUE 1. P. 23 -38 | 54 | 49% | 25 |
| 9 | MASSON, O , BACH, AS , DEROCQ, D , PREBOIS, C , LAURENT-MATHA, V , PATTINGRE, S , LIAUDET-COOPMAN, E , (2010) PATHOPHYSIOLOGICAL FUNCTIONS OF CATHEPSIN D: TARGETING ITS CATALYTIC ACTIVITY VERSUS ITS PROTEIN BINDING ACTIVITY?.BIOCHIMIE. VOL. 92. ISSUE 11. P. 1635-1643 | 58 | 37% | 40 |
| 10 | VETVICKA, V , FUSEK, M , (2012) PROCATHEPSIN D AS A TUMOR MARKER, ANTI-CANCER DRUG OR SCREENING AGENT.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 2. P. 172-175 | 29 | 76% | 4 |
Classes with closest relation at Level 1 |